Cysteine rich protective antigen

Product list
The leading vaccine candidates for a P. falciparum blood-stage malaria vaccine are members of a heterotrimeric complex containing reticulocyte-binding protein homolog 5 (RH5), cysteinerich protective antigen (CyRPA), and RH5-interacting protein (RIPR), collectively called the "RCR complex"15. Each member of this complex is highly conserved, essential for erythrocyte invasion, and capable of inducing cross-strain neutralizing antibodies. The leading blood-stage malaria vaccine candidate, CyRPA, is essential for invasion of Plasmodium falciparum into human erythrocytes.
Show More Close

Inquiry

Anti-CyRPA Neutralizing Antibody (V3S-0522-YC945) (CAT#: V3S-0522-YC945)

Target: CyRPA

Host Species: Mouse

Target Species: Plasmodium falciparum,

Application: ELISA,WB,Inhib,

Inquiry

CyRPA (blade 2) Specific Neutra™ Antibody (V3S-0923-XY8), Human IgG1 (CAT#: V3S-0923-XY8)

Target: CyRPA

Host Species: Human

Target Species: Plasmodium falciparum,

Application: ELISA,SPR,Inhib,

Inquiry

CyRPA (blade 3 and 4) Specific Neutra™ Antibody (V3S-0923-XY9), Mouse IgG1 (CAT#: V3S-0923-XY9)

Target: CyRPA

Host Species: Mouse

Target Species: Plasmodium falciparum,

Application: ELISA,SPR,

For research use only, not directly for clinical use.


banner banner
© 2025 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry